128 related articles for article (PubMed ID: 8551061)
1. Evaluation of lipid-bound sialic acid (LSA) as a tumor marker.
López Sáez JJ; Senra-Varela A
Int J Biol Markers; 1995; 10(3):174-9. PubMed ID: 8551061
[TBL] [Abstract][Full Text] [Related]
2. Plasma lipid-bound sialic acid alterations in neoplastic diseases.
Dwivedi C; Dixit M; Hardy RE
Experientia; 1990 Jan; 46(1):91-4. PubMed ID: 2298288
[TBL] [Abstract][Full Text] [Related]
3. [Serum lipid-bound sialic acid as a marker in lung cancer patients].
Iwahashi N
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1599-607. PubMed ID: 2077205
[TBL] [Abstract][Full Text] [Related]
4. [Relation between lipid-bound sialic acid in blood serum and plasma andin human tumors].
Polívková J; Vosmiková K; Pospísil J; Poucková P
Bratisl Lek Listy; 1992 May; 93(5):222-4. PubMed ID: 1393642
[TBL] [Abstract][Full Text] [Related]
5. Utilization of determining lipid-bound sialic acid for the diagnosis and further prognosis of cancer.
Polívková J; Vosmiková K; Horák L
Neoplasma; 1992; 39(4):233-6. PubMed ID: 1436234
[TBL] [Abstract][Full Text] [Related]
6. Lipid bound sialic acid in cancer patients.
Salvagno L; Ferrazzi E; Sileni VC; Maggi S; Tredese F; Bedendo C; Russo MP; Fiorentino MV; Ceriotti G
Tumori; 1985 Apr; 71(2):127-33. PubMed ID: 4002346
[TBL] [Abstract][Full Text] [Related]
7. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
Schutter EM; Visser JJ; van Kamp GJ; Mensdorff-Pouilly S; van Dijk W; Hilgers J; Kenemans P
Tumour Biol; 1992; 13(3):121-32. PubMed ID: 1626178
[TBL] [Abstract][Full Text] [Related]
8. Utility of serum activity of angiotensin-converting enzyme as a tumor marker.
Varela AS; Bosco Lopez Saez JJ
Oncology; 1993; 50(6):430-5. PubMed ID: 8233282
[TBL] [Abstract][Full Text] [Related]
9. Role of sialic acid and alkaline DNase in breast cancer.
Raval GN; Parekh LJ; Patel MM; Patel PS; Rawal RM; Balar DB; Patel DD
Int J Biol Markers; 1997; 12(2):61-7. PubMed ID: 9342634
[TBL] [Abstract][Full Text] [Related]
10. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
Kakari S; Stringou E; Toumbis M; Ferderigos AS; Poulaki E; Chondros K; Dema A; Kotsovoulou V; Pavlidis N
Anticancer Res; 1991; 11(6):2107-10. PubMed ID: 1663720
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of serum lipid-bound sialic acid and carcinoembryonic antigen in patients with lung cancer].
Zhu X
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb; 13(1):25-7, 61. PubMed ID: 2165867
[TBL] [Abstract][Full Text] [Related]
12. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.
Stringou E; Chondros K; Kouvaris J; Kakari S; Papavassiliou K
Anticancer Res; 1992; 12(1):251-5. PubMed ID: 1567173
[TBL] [Abstract][Full Text] [Related]
13. The significance of serum lipid-bound sialic acid in bladder tumours.
Oztokatli A; Ozkardeş H; Ovül E; Erol D
Int Urol Nephrol; 1992; 24(2):125-9. PubMed ID: 1624255
[TBL] [Abstract][Full Text] [Related]
14. Lipid-bound sialic acid as a tumor marker.
Dnistrian AM; Schwartz MK
Ann Clin Lab Sci; 1983; 13(2):137-42. PubMed ID: 6859805
[TBL] [Abstract][Full Text] [Related]
15. [Behavior of serum sialic acid levels at various stages of neoplastic disease].
Adamo V; Altavilla G; Caristi N; Chillemi S; Giacobello T; Scalisi R; Palmara D
Minerva Med; 1985 Nov; 76(43):2067-70. PubMed ID: 4069416
[TBL] [Abstract][Full Text] [Related]
16. A critical analysis of the use of sialic acid determination in the diagnosis of malignancy.
O'Kennedy R; Berns G; Moran E; Smyth H; Carroll K; Thornes RD; O'Brien A; Fennelly J; Butler M
Cancer Lett; 1991 Jun; 58(1-2):91-100. PubMed ID: 2049789
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma antigen and protein-bound sialic acid in the management of head and neck cancer.
Bhatavdekar JM; Patel DD; Vora HH; Balar DB
Int J Biol Markers; 1991; 6(4):237-40. PubMed ID: 1795131
[TBL] [Abstract][Full Text] [Related]
18. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
[TBL] [Abstract][Full Text] [Related]
19. Assessing benefits of combining biochemical and immunological markers in patients with lung carcinoma.
Patel PS; Raval GN; Rawal RR; Patel GH; Balar DB; Shah PM; Patel DD
Cancer Lett; 1994 Jul; 82(2):129-33. PubMed ID: 8050082
[TBL] [Abstract][Full Text] [Related]
20. Serum lipid-bound sialic acid as a marker in breast cancer.
Dnistrian AM; Schwartz MK; Katopodis N; Fracchia AA; Stock CC
Cancer; 1982 Nov; 50(9):1815-9. PubMed ID: 7116306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
